QSimulate

QSimulate develops quantum-powered simulation solutions designed to help pharmaceutical and biotechnology teams accelerate drug discovery. By applying quantum mechanics to industrial-scale scientific problems, the company aims to shorten research and development timelines and improve the chances of advancing promising therapeutic candidates. Its products support several stages of discovery: QUELO helps with lead optimization, QuValent is designed for covalent binder design, and QuantumFP generates data for artificial intelligence models. QSimulate also offers other quantum solutions and describes its technology as a way to bring scalable, high-quality quantum chemistry calculations into research workflows.

The company’s tools are used in computational drug discovery and have been incorporated into partner organizations’ research platforms and campaigns. Customer feedback highlights applications including relative free-energy calculations, compound prioritization, and efforts to improve biochemical potency and binding-affinity predictions. QSimulate’s team includes scientists and engineers focused on developing quantum-based tools for pharmaceutical research. Based in Boston, Massachusetts, the company shares product updates, research news, and information about its technology and career opportunities through its website.